Literature DB >> 27418331

miRNAs Related to Skeletal Diseases.

Claudine Seeliger1, Elizabeth R Balmayor1, Martijn van Griensven1.   

Abstract

miRNAs as non-coding, short, double-stranded RNA segments are important for cellular biological functions, such as proliferation, differentiation, and apoptosis. miRNAs mainly contribute to the inhibition of important protein translations through their cleavage or direct repression of target messenger RNAs expressions. In the last decade, miRNAs got in the focus of interest with new publications on miRNAs in the context of different diseases. For many types of cancer or myocardial damage, typical signatures of local or systemically circulating miRNAs have already been described. However, little is known about miRNA expressions and their molecular effect in skeletal diseases. An overview of published studies reporting miRNAs detection linked with skeletal diseases was conducted. All regulated miRNAs were summarized and their molecular interactions were illustrated. This review summarizes the involvement and interaction of miRNAs in different skeletal diseases. Thereby, 59 miRNAs were described to be deregulated in tissue, cells, or in the circulation of osteoarthritis (OA), 23 miRNAs deregulated in osteoporosis, and 107 miRNAs deregulated in osteosarcoma (OS). The molecular influences of miRNAs regarding OA, osteoporosis, and OS were illustrated. Specific miRNA signatures for skeletal diseases are described in the literature. Some overlapped, but also unique ones for each disease exist. These miRNAs may present useful targets for the development of new therapeutic approaches and are candidates for diagnostic evaluations.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27418331     DOI: 10.1089/scd.2016.0133

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  14 in total

Review 1.  Epigenetics of Skeletal Diseases.

Authors:  Alvaro Del Real; Leyre Riancho-Zarrabeitia; Laura López-Delgado; José A Riancho
Journal:  Curr Osteoporos Rep       Date:  2018-06       Impact factor: 5.096

Review 2.  The Therapeutic Potential of MicroRNAs as Orthobiologics for Skeletal Fractures.

Authors:  Michael Hadjiargyrou; David E Komatsu
Journal:  J Bone Miner Res       Date:  2019-03-28       Impact factor: 6.741

3.  Downregulation of microRNA-16-5p accelerates fracture healing by promoting proliferation and inhibiting apoptosis of osteoblasts in patients with traumatic brain injury.

Authors:  Yun Sun; Yuan Xiong; Chenchen Yan; Lang Chen; Dong Chen; Bobin Mi; Guohui Liu
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

4.  miRNA-338-3p/CDK4 signaling pathway suppressed hepatic stellate cell activation and proliferation.

Authors:  Bensong Duan; Jiangfeng Hu; Tongyangzi Zhang; Xu Luo; Yi Zhou; Shun Liu; Liang Zhu; Cheng Wu; Wenxiang Liu; Chao Chen; Hengjun Gao
Journal:  BMC Gastroenterol       Date:  2017-01-17       Impact factor: 3.067

5.  Evaluation of circulating miRNAs during late pregnancy in the mare.

Authors:  Shavahn C Loux; Kirsten E Scoggin; Jason E Bruemmer; Igor F Canisso; Mats H T Troedsson; Edward L Squires; Barry A Ball
Journal:  PLoS One       Date:  2017-04-07       Impact factor: 3.240

Review 6.  Micrornas at the Interface between Osteogenesis and Angiogenesis as Targets for Bone Regeneration.

Authors:  Leopold F Fröhlich
Journal:  Cells       Date:  2019-02-03       Impact factor: 6.600

Review 7.  Designing biomaterials for the delivery of RNA therapeutics to stimulate bone healing.

Authors:  L Andrée; F Yang; R Brock; S C G Leeuwenburgh
Journal:  Mater Today Bio       Date:  2021-03-06

Review 8.  The future of basic science in orthopaedics and traumatology: Cassandra or Prometheus?

Authors:  Henning Madry; Susanne Grässel; Ulrich Nöth; Borna Relja; Anke Bernstein; Denitsa Docheva; Max Daniel Kauther; Jan Christoph Katthagen; Rainer Bader; Martijn van Griensven; Dieter C Wirtz; Michael J Raschke; Markus Huber-Lang
Journal:  Eur J Med Res       Date:  2021-06-14       Impact factor: 2.175

9.  Overexpression of SENP1 reduces the stemness capacity of osteosarcoma stem cells and increases their sensitivity to HSVtk/GCV.

Authors:  Fengting Liu; Lili Li; Yanxia Li; Xiaofang Ma; Xiyun Bian; Xiaozhi Liu; Guowen Wang; Dianying Zhang
Journal:  Int J Oncol       Date:  2018-08-23       Impact factor: 5.650

10.  Upregulation of miR-107 expression following hyperbaric oxygen treatment suppresses HMGB1/RAGE signaling in degenerated human nucleus pulposus cells.

Authors:  Chi-Chien Niu; Song-Shu Lin; Li-Jen Yuan; Meng-Ling Lu; Steve W N Ueng; Chuen-Yung Yang; Tsung-Ting Tsai; Po-Liang Lai
Journal:  Arthritis Res Ther       Date:  2019-01-31       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.